Nonspecific immunotherapies often induce general immune activation or suppression.
Conversely, antigen‐specific immunotherapy, which refers to dampening or augmenting …

Impairment of immune tolerance might cause autologous tissue damage or overactive
immune response against non-pathogenic molecules. Although autoimmune disease and …

The tumor immune microenvironment (TIME) is comprised of a complex milieu that
contributes to stunting antitumor immune responses by restricting T cells to accumulate in …

The intersection of immunology and nanotechnology has provided significant advancements
in biomedical research and clinical applications over the years. Immunology aims to …

Immunotherapy has firmly established itself as a compelling avenue for treating disease.
Although many clinically approved immunotherapeutics engage the adaptive immune …

Combined therapeutic strategies hold promises in augmenting antigen release to enhance
anti-tumor immunity, which have garnered attention in numerous scholarly reviews. Beyond …

With the rapid growth of advanced nanoengineering strategies, there are great implications
for therapeutic immunostimulators formulated in nanomaterials to combat cancer. It is crucial …

Immunotherapy has emerged as an effective strategy for the prevention and treatment of a
variety of diseases, including cancer, infectious diseases, inflammatory diseases, and …

Tolerogenic immunotherapy aims to blunt pathogenic inflammation without affecting
systemic immunity. However, the anti-inflammatory drugs and immunosuppressive biologics …

In article number 2008094, Haijun Yu and co-workers explore how nanomedicines target
immunosuppressive cells and signaling pathways to broaden the impact of cancer …